|
Nitro-bidDrug - Nitro-bid The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Nitroglycerin
Strength -
5MG/ML
Applicant -
AVENTIS PHARMS
New Drug Application (NDA) Number -
018621
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 5, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Aventis Pharmaceuticals Inc
Nitro-bid
Transderm-nitro 0.1mg/hr Film, Extended Release; Transdermal
Transderm-nitro 0.2mg/hr Film, Extended Release; Transdermal Transderm-nitro 0.4mg/hr Film, Extended Release; Transdermal Transderm-nitro 0.6mg/hr Film, Extended Release; Transdermal Transderm-nitro 0.8mg/hr Film, Extended Release; Transdermal Nitro Iv 5mg/ml Injectable; Injection Nitro-bid 10mg/ml Injectable; Injection Nitro-bid 5mg/ml Injectable; Injection Nitroglycerin 0.6mg/hr Film, Extended Release; Transdermal Nitroglycerin 0.6mg/hr Film, Extended Release; Transdermal NewDrugInformation |